167 related items for PubMed ID: 9205763
1. Ebrotidine versus ranitidine in the healing and prevention of relapse of duodenal ulcer. A multicentre, double-blind, parallel, randomized, controlled study.
Tulassay Z, Döbrönte Z, Farkas I, Juhász L, Simon L, Prónai L, Torres J, Márquez M.
Arzneimittelforschung; 1997 Apr; 47(4A):551-5. PubMed ID: 9205763
[Abstract] [Full Text] [Related]
2. Ebrotidine versus ranitidine in the treatment of acute duodenal ulcer. A multicentre, randomized, double-blind, controlled clinical trial.
Matov V, Metchkov G, Krastev Z, Tchernev K, Mitova R, Márquez M, Torres J, Herrero E, Fillat O, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):555-9. PubMed ID: 9205764
[Abstract] [Full Text] [Related]
3. Efficacy of ebrotidine and ranitidine in the treatment of benign gastric ulcer.
Gedliczka O, Bobrzynski A, Rembiasz K, Fillat O, Torres J, Herrero E, Márquez M, Camps F, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):560-4. PubMed ID: 9205765
[Abstract] [Full Text] [Related]
4. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study.
Gabryelewicz A, Czajkowski A, Skrodzka D, Marlicz K, Luca de Tena F, Aldeguer M, Chantar C, Márquez M, Torres J, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):545-50. PubMed ID: 9205762
[Abstract] [Full Text] [Related]
5. Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer.
Popiela T, Kulig J, Karcz D, Tabor J, Torres J, Márquez M, Fillat O, Herrero E, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):573-7. PubMed ID: 9205768
[Abstract] [Full Text] [Related]
6. Comparative study of the safety and efficacy of ebrotidine versus ranitidine and placebo in the prevention of piroxicam-induced gastroduodenal lesions.
Puscas I, Puscas C, Coltau M, Pasca R, Torres J, Márquez M, Herrero E, Fillat O, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):568-72. PubMed ID: 9205767
[Abstract] [Full Text] [Related]
7. Efficacy and safety of ebrotidine compared with ranitidine in patients with duodenal ulcer.
Gabryelewicz A, Konturek SJ, Butruk E, Dzieniszewski J, Marlicz K, Nowak A, Torres J, Marquez M, Ortiz JA.
Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):361-6. PubMed ID: 7600143
[Abstract] [Full Text] [Related]
8. Studies on the protective effect of ebrotidine on experimental ulcers induced by non-steroidal anti-inflammatory drugs in healthy volunteers.
Puscas I, Puscas C, Coltau M, Torres J, Márquez M, Herrero E, Fillat O, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):565-8. PubMed ID: 9205766
[Abstract] [Full Text] [Related]
9. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D, Agut J, Márquez M, Conejo L, Sacristán A, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[Abstract] [Full Text] [Related]
10. Nizatidine and ranitidine in the short-term treatment of duodenal ulcer: a cooperative double-blind study of once-daily bedtime administration.
Pace F, Colombo E, Ferrara A, Prada A, Rocca F, Bianchi Porro G.
Am J Gastroenterol; 1988 Jun; 83(6):643-5. PubMed ID: 2897784
[Abstract] [Full Text] [Related]
11. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
Sevvel S, Ananthakrishnan N, Kate V.
Trop Gastroenterol; 1996 Jun; 17(4):227-9. PubMed ID: 9094865
[Abstract] [Full Text] [Related]
12. Continuous intragastric pH monitoring in the evaluation of ebrotidine, cimetidine and placebo on gastric acidity in healthy volunteers.
Muñoz-Navas M, Honorato J, Reina-Ariño M, Márquez M, Herrero E, Villamayor F, Torres J, Roset PN, Fíllat O, Camps F, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):539-44. PubMed ID: 9205761
[Abstract] [Full Text] [Related]
13. The effect of omeprazole and ranitidine on ulcer healing, relief of symptoms, and incidence of adverse events in the treatment of duodenal ulcer patients.
Kager L, Lindberg G, Nilsson LH, Seensalu R, Backman L, Granström L, Kollberg B, Sidenvall L, Moberg S, Sörstad J.
Hepatogastroenterology; 1991 Aug; 38(4):287-90. PubMed ID: 1937372
[Abstract] [Full Text] [Related]
14. Nizatidine in the short-term treatment of duodenal ulcer--an Italian Multicenter Study.
Bovero E, Poletti M, Boero A, Mura BC, Camarri E, Corradini P, Corsini G, Federici G, Curzio M, Gianquinto G.
Hepatogastroenterology; 1987 Dec; 34(6):269-71. PubMed ID: 2892768
[Abstract] [Full Text] [Related]
15. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
Kachintorn U, Chinapak O, Vongphanich V, Kositchaiwat C, Lekhayananda S, Khow-ean U, Suttinont C, Saowaros V, Kludchareon N, Leethochawalit M.
J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
[Abstract] [Full Text] [Related]
16. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
Kuipers EJ, Hazenberg HJ, Quik RF, Hazenberg BP, de Zwart PA.
Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089
[Abstract] [Full Text] [Related]
17. [Dose comparative study with ranitidine in the therapy and prevention of duodenal ulcer].
Paul F, Neuhaus H, Homann J, Kamenisch W, Eimiller A.
Z Gastroenterol; 1986 Mar; 24(3):141-8. PubMed ID: 3085363
[Abstract] [Full Text] [Related]
18. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A, Dattilo M.
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[Abstract] [Full Text] [Related]
19. Pharmacokinetic study of ebrotidine administered in multiple doses to healthy volunteers for 4 days.
Frías J, Esteban C, Carcas AJ, Sánchez-García P, Albet C, Torres J, Márquez M, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):531-4. PubMed ID: 9205759
[Abstract] [Full Text] [Related]
20. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
Palop D, Romero A, Villamayor F, Conejo L, Sacristán A, Ortiz JA.
Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
